Latest property, plant & equipment for ECTE: $190K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2016), ECTE shows a PP&E of $190K. That compares with $300K in the prior-year period — down 37.4% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ECTE's PP&E is now $190K (was $300K) — a 37.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Echo Therapeutics is outperforming or lagging.
Tracking ECTE's property, plant & equipment over time shows whether Echo Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $190K That compares with $300K in the prior-year period — down 37.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this property, plant & equipment page, Stockcircle has Echo Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PP&E (currently $190K) with ownership activity and broader fundamentals.